v3.26.1
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

12,713

 

 

$

12,435

 

CMO-related accrual

 

 

5,853

 

 

 

8,525

 

Clinical trials-related accrual

 

 

504

 

 

 

6,263

 

Tax and related expenses

 

 

 

 

 

18

 

Restructuring related accrual

 

 

12,598

 

 

 

 

Other

 

 

2,913

 

 

 

4,009

 

Total accrued expenses and other current liabilities

 

$

34,581

 

 

$

31,250